Cargando…
Dysregulation of protein methyltransferases in human cancer: An emerging target class for anticancer therapy
Protein methylation is one of the important post‐translational modifications. Although its biological and physiological functions were unknown for a long time, we and others have characterized a number of protein methyltransferases, which have unveiled the critical functions of protein methylation i...
Autores principales: | Hamamoto, Ryuji, Nakamura, Yusuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832871/ https://www.ncbi.nlm.nih.gov/pubmed/26751963 http://dx.doi.org/10.1111/cas.12884 |
Ejemplares similares
-
Automethylation of SUV39H2, an oncogenic histone lysine methyltransferase, regulates its binding affinity to substrate proteins
por: Piao, Lianhua, et al.
Publicado: (2016) -
Protein lysine methyltransferase SMYD3 is involved in tumorigenesis through regulation of HER2 homodimerization
por: Yoshioka, Yuichiro, et al.
Publicado: (2017) -
Dysregulation of AKT Pathway by SMYD2-Mediated Lysine Methylation on PTEN()()
por: Nakakido, Makoto, et al.
Publicado: (2015) -
Protein arginine methyltransferase 5 (PRMT5) dysregulation in cancer
por: Shailesh, Harshita, et al.
Publicado: (2018) -
Protein arginine methyltransferases: promising targets for cancer therapy
por: Hwang, Jee Won, et al.
Publicado: (2021)